# Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia

> **NCT03067688** · PHASE3 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 202 (actual)

## Conditions studied

- Hypertension
- Hyperlipidemia

## Interventions

- **DRUG:** Temisartan+Amlodipine+Rosuvastatin (Combination drug)
- **DRUG:** Temisartan+Amlodipine
- **DRUG:** Temisartan+Rosuvastatin

## Key facts

- **NCT ID:** NCT03067688
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-11
- **Primary completion:** 2018-03-27
- **Final completion:** 2018-03-27
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03067688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03067688, "Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03067688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*